Increased circulating dendritic cells in healthy human volunteers following administration of Flt3 ligand alone or in combination with GM-CSF or G-CSF.

被引:0
|
作者
Lebsack, ME [1 ]
Maraskovsky, E [1 ]
Roux, E [1 ]
Teepe, M [1 ]
Hirschstein, D [1 ]
Hoek, J [1 ]
McKenna, HJ [1 ]
Maliszewski, C [1 ]
Caron, D [1 ]
机构
[1] Immunex Corp, Seattle, WA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2086
引用
收藏
页码:507A / 507A
页数:1
相关论文
共 50 条
  • [41] Acute graft versus host disease following transplantation of splenocytes from murine donors treated with Flt3 ligand (FL), FL+GM-CSF or FL+G-CSF
    McKenna, HJ
    Webster, M
    Widmer, B
    BLOOD, 1997, 90 (10) : 911 - 911
  • [42] Progenipoietin, a chimeric receptor agonist for human Flt3 and G-CSF receptors increases dendritic cells in lymphoid organs.
    Lie, WR
    Yu, M
    Kahn, LE
    McGarity, K
    Doshi, PD
    Klein, BK
    Woulfe, SL
    FASEB JOURNAL, 2000, 14 (06): : A1135 - A1135
  • [43] PROLIFERATIVE RESPONSE OF HUMAN ACUTE MYELOID-LEUKEMIA CELLS AND NORMAL MARROW ENRICHED PROGENITOR CELLS TO HUMAN RECOMBINANT GROWTH-FACTORS IL-3, GM-CSF AND G-CSF ALONE AND IN COMBINATION
    LEMOLI, RM
    GULATI, SC
    STRIFE, A
    LAMBEK, C
    PEREZ, A
    CLARKSON, BD
    LEUKEMIA, 1991, 5 (05) : 386 - 391
  • [44] HER-2/NEU (HER2) peptide based vaccine with FLT3 ligand (FL) +/- GM-CSF as an adjuvant.
    Disis, ML
    Rinn, K
    Davis, D
    Caron, D
    Schiffman, K
    BLOOD, 2000, 96 (11) : 456A - 456A
  • [45] Generation of high cross-presentation ability human dendritic cells by combination of interleukin 4, interferon β and GM-CSF
    Pi, Yihua
    Li, Yifang
    Liang, Rongyi
    Xiao, Jian
    Leng, Jing
    Zhang, Lifeng
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 47 (02) : 125 - 138
  • [46] Comparison between G-CSF and GM-CSF for mobilization of dendritic cells, CD34+cells, and CD3+cells in normal donors.
    Shaughnessy, P
    Bachier, C
    Long, L
    LeMaistre, CF
    Gazitt, Y
    BLOOD, 2002, 100 (11) : 827A - 827A
  • [47] Comparison between G-CSF and GM-CSF for mobilization of dendritic cells, CD34+cells, and CD3+cells in normal donors.
    Shaughnessy, PJ
    Bachier, C
    Nanez, A
    Akay, C
    LeMaistre, CF
    Gazitt, Y
    BLOOD, 2004, 104 (11) : 785A - 785A
  • [48] Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF
    Rosenfeld, CS
    Bolwell, B
    LeFever, A
    Taylor, R
    List, A
    Fay, J
    Collins, R
    Andrews, F
    Pallansch, P
    Schuster, MW
    Resta, D
    Levitt, D
    Nemunaitis, J
    BONE MARROW TRANSPLANTATION, 1996, 17 (02) : 179 - 183
  • [49] A randomized prospective study of peripheral blood stem cell (PBSC) mobilization with cyclophosphamide (CTX) in combination with G-CSF, GM-CSF, or sequential GM-CSF followed by G-CSF, in non-hodgkin's lymphoma (NHL) patients: Co-mobilization of dendritic cells and NK cells.
    Gazitt, Y
    Fey, V
    Shaughnessy, P
    Devore, P
    BLOOD, 1999, 94 (10) : 637A - 637A
  • [50] Radioprotection by FLT3 ligand combined with G-CSF following high dose total body irradiation in rabbits.
    WodnarFilipowicz, A
    John, L
    Baldomero, H
    Speck, B
    Lyman, SD
    Gratwohl, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 637 - 637